全文获取类型
收费全文 | 49893篇 |
免费 | 3949篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 470篇 |
儿科学 | 1861篇 |
妇产科学 | 1306篇 |
基础医学 | 6268篇 |
口腔科学 | 455篇 |
临床医学 | 6333篇 |
内科学 | 9152篇 |
皮肤病学 | 1033篇 |
神经病学 | 5067篇 |
特种医学 | 988篇 |
外科学 | 5194篇 |
综合类 | 409篇 |
现状与发展 | 1篇 |
一般理论 | 87篇 |
预防医学 | 7013篇 |
眼科学 | 850篇 |
药学 | 3467篇 |
中国医学 | 60篇 |
肿瘤学 | 3937篇 |
出版年
2024年 | 57篇 |
2023年 | 514篇 |
2022年 | 821篇 |
2021年 | 1826篇 |
2020年 | 1112篇 |
2019年 | 1808篇 |
2018年 | 1930篇 |
2017年 | 1483篇 |
2016年 | 1566篇 |
2015年 | 1649篇 |
2014年 | 2320篇 |
2013年 | 3018篇 |
2012年 | 4518篇 |
2011年 | 4432篇 |
2010年 | 2426篇 |
2009年 | 2015篇 |
2008年 | 3494篇 |
2007年 | 3430篇 |
2006年 | 3186篇 |
2005年 | 2996篇 |
2004年 | 2587篇 |
2003年 | 2168篇 |
2002年 | 1900篇 |
2001年 | 236篇 |
2000年 | 165篇 |
1999年 | 247篇 |
1998年 | 306篇 |
1997年 | 223篇 |
1996年 | 179篇 |
1995年 | 164篇 |
1994年 | 120篇 |
1993年 | 99篇 |
1992年 | 74篇 |
1991年 | 58篇 |
1990年 | 74篇 |
1989年 | 71篇 |
1988年 | 62篇 |
1987年 | 50篇 |
1986年 | 42篇 |
1985年 | 42篇 |
1984年 | 51篇 |
1983年 | 42篇 |
1982年 | 31篇 |
1981年 | 33篇 |
1980年 | 29篇 |
1979年 | 31篇 |
1978年 | 29篇 |
1975年 | 29篇 |
1973年 | 28篇 |
1972年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
991.
Jennifer M. Logue Elisa Zucchetti Christina A. Bachmeier Gabriel S. Krivenko Victoria Larson Daniel Ninh Giovanni Grillo Biwei Cao Jongphil Kim Julio C. Chavez Aliyah Baluch Farhad Khimani Aleksandr Lazaryan Taiga Nishihori Hien D. Liu Javier Pinilla-Ibarz Bijal D. Shah Rawan Faramand Anna E. Coghill Marco L. Davila Bhagirathbhai R. Dholaria Michael D. Jain Frederick L. Locke 《Haematologica》2021,106(4):978
CD19 chimeric antigen receptor T (CAR T)-cell therapy with axicabtagene ciloleucel (axi-cel) for relapsed or refractory (R/R) large B-cell lymphoma (LBCL) may lead to durable remissions, however, prolonged cytopenias and infections may occur. In this single center retrospective study of 85 patients, we characterized immune reconstitution and infections for patients remaining in remission after axi-cel for LBCL. Prolonged cytopenias (those occurring at or after day 30 following infusion) were common with ≥grade 3 neutropenia seen in 21 of 70 (30%) patients at day 30 and persisting in 3 of 31 (9.7%) patients at 1 year. B cells were undetectable in 30 of 34 (88.2%) patients at day 30, but were detected in 11 of 19 (57.9%) at 1 year. Median immunoglobulin G levels levels reached a nadir at day 180. By contrast, CD4 T cells decreased from baseline and were persistently low with a median CD4 count of 155 cells/mL at 1 year after axi-cel (n=19, range: 33– 269). In total, 23 of 85 (27.1%) patients received intravenous immunoglobulins after axi-cel, and 34 of 85 (40%) received granulocyte-colony stimulating factor. Infections in the first 30 days occurred in 31 of 85 (36.5%) patients, of which 11 of 85 (12.9%) required intravenous antibiotics or hospitalization (“severe”) and were associated with cytokine release syndrome, neurotoxicity, tocilizumab use, corticosteroid use, and bridging therapy on univariate analyses. After day 30, seven severe infections occurred, with no late deaths due to infection. Prolonged cytopenias are common following axi-cel therapy for LBCL and typically recover with time. Most patients experience profound and prolonged CD4 T-cell immunosuppression without severe infection. 相似文献
992.
993.
994.
Eastin Jennifer Dey Dzifa Amissah-Arthur Maame-Boatemaa Chaudhuri Kaushik Jawad Ali 《Clinical rheumatology》2021,40(9):3439-3443
Clinical Rheumatology - A project aimed to develop and deliver a clinical training course in Accra, Ghana, to increase patient access to physicians trained in the diagnosis, treatment and... 相似文献
995.
Singh Jasvinder A. Richards John S. Chang Elizabeth Toupin-April Karine Barton Jennifer L. 《Clinical rheumatology》2021,40(2):693-700
Clinical Rheumatology - To assess rheumatologists’ views and practices related to shared decision-making (SDM) in gout treatment. We performed a cross-sectional electronic survey of... 相似文献
996.
Amirahmadi Roxana Sullivan Scott Britton Noel Siegel Ariel Spiegel Rory Miceli Jennifer Duong Vu Sholander Jeffrey T. Fontaine Magali J. McCurdy Michael T. 《Annals of hematology》2022,101(9):2045-2052
Annals of Hematology - Despite the low risk of peripherally inserted central catheter (PICC) insertion-related bleeding, the practice of administering prophylactic platelets varies greatly.... 相似文献
997.
Georg Stachel Felix J. Woitek Lisa Crusius Stephan Haussig Philipp Kiefer Sergey Leontyev Florian Schlotter Aileen Spindler Robert Höllriegel Jennifer Hommel Michael A. Borger Holger Thiele David Holzhey Axel Linke Norman Mangner 《The Canadian journal of cardiology》2021,37(3):450-457
BackgroundData about the impact of left-atrial appendage thrombosis (LAAT) on early safety and mortality in patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI) are scarce. We aimed to investigate the prevalence and predictors of LAAT and the outcome associated with this condition in patients treated by TF-TAVI.MethodsRetrospective data analysis was derived from a prospective single-centre registry comparing patients with and without LAAT regarding early safety at 30 days, according to Valve Academic Research Consortium-2 (VARC-2) and 2-year mortality.ResultsLAAT was found in 7.6% of the whole cohort (n = 2527) and in 16.6% in those patients with known pre-existing atrial fibrillation (AF cohort, n = 1099). Compared with controls, patients with LAAT were sicker, indicated by a higher Society of Thoracic Surgeons (STS) score and burden of comorbidities. Neither VARC-2–defined early safety at 30 days nor the rate of stroke was different between LAAT and controls in both the whole (early safety: 29.2% vs 24.2%, P = 0.123; stroke: 5.9% vs 4.7%, P = 0.495) and AF cohort (early safety: 29.1% vs 22.9%, P = 0.072; stroke: 5.6% vs 3.3%, P = 0.142). Evaluating the whole cohort in a univariate analysis, the 2-year mortality was significantly higher in LAAT compared with controls (hazard ratio, 1.41; 95% confidence interval, 1.07-1.86; P = 0.014). However, multivariate analysis of the whole cohort and the AF cohort revealed no association between LAAT and 2-year mortality.ConclusionsLAAT was frequent in patients undergoing TF-TAVI— in particular, in patients with histories of AF—but it was not associated with an increase in periprocedural complications and did not predict 2-year mortality. 相似文献
998.
Diana Azevedo Jennifer Mancio Guilherme Pessoa-Amorim David Monteiro Nuno Almeida Ricardo Ladeiras-Lopes Rita Faria Nuno Ferreira Luís Vouga Vasco Gama Ribeiro Adelino Leite-Moreira Nuno Bettencourt 《Revista portuguesa de cardiologia》2021,40(3):153-164
Introduction and objectivesIn severe aortic stenosis (AS), the impact of aortic valve replacement (AVR) on left ventricular (LV) systolic function assessed by strain and measured by echocardiography or cardiac magnetic resonance (CMR) has been controversial. We aimed to investigate LV systolic myocardial function changes six months after AVR using global longitudinal (GLS), circumferential (GCS) and radial (GRS) strain derived from CMR imaging.MethodsWe included 39 severe AS patients (69.3±7.8 years; 61.5% male) with preserved LV ejection fraction (LVEF) who were recruited as part of the EPICHEART study and underwent successful AVR (aortic valvular area: 0.8 cm2 (IQR: 0.2) pre- to 1.8 cm2 (IQR:0.5) post-AVR). Structural and functional parameters were assessed at baseline and six months after AVR, including LV GRS, GCS and GLS analysis by CMR, using cine short-axial and two-, three-, and four-chamber long-axial view. Comparison between baseline and postoperative LV remodeling was performed using Student t-test and Wilcoxon test.ResultsAt six-month follow-up, LV mass, end-diastolic and end-systolic volumes, stroke volume, cardiac output, lateral E/e’, tricuspid annular plane systolic excursion, right ventricular (RV) S wave velocity, GLS [-15.6% (IQR: 4.39) to -13.7% (IQR: 4.62)] and GCS [-17.8±3.58% to -16.1±2.94%] reduced significantly, while LVEF and GRS remained unchanged and lateral e’ velocity increased.ConclusionsDespite favorable reverse LV structural and diastolic functional remodeling six months following AVR, GLS and GCS assessed by CMR reduced compared to baseline, LVEF remained unchanged. The clinical utility and timing of assessment of postoperative strain changes as a marker of systolic function progression needs further research. 相似文献
999.
1000.
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
McGlynn Fergal McGrath Jennifer Varghese Chithra Ryan Barbara McHugh Johnny Fahy Arabella Enright Helen 《Journal of thrombosis and thrombolysis》2021,51(1):243-245
Journal of Thrombosis and Thrombolysis - 相似文献